2009

1. Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: A phase II study of the Spanish GOTI group

   British Journal of Cancer, Vol. 101, Núm. 7, pp. 1039-1043